サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1363306

経カテーテル塞栓・閉鎖機器の市場規模、シェア、動向分析レポート：製品別、用途別、地域別、セグメント別予測、2023年～2030年

Transcatheter Embolization And Occlusion Devices Market Size, Share & Trends Analysis Report By Product (Coil, Non Coil), By Application (Peripheral Vascular Disease, Oncology, Neurology, Urology), By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 210 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
経カテーテル塞栓・閉鎖機器の市場規模、シェア、動向分析レポート：製品別、用途別、地域別、セグメント別予測、2023年～2030年
出版日: 2023年09月27日
発行: Grand View Research
ページ情報: 英文 210 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

経カテーテル塞栓・閉鎖機器市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、経カテーテル塞栓・閉鎖機器の世界市場規模は、2023年から2030年にかけて7.0％のCAGRを記録し、2030年までに85億4,000万米ドルに達すると予測されています。

世界市場は2019年から2026年にかけて9.7％の力強いCAGRを記録すると予測されています。TEO装置市場の主な促進要因には、低侵襲手術の採用増加やがん有病率の上昇が含まれます。

また、血管奇形や線維症など、がん以外の疾患の治療法として塞栓術が広く使用されていることが、世界的にTEO機器の需要を促進しています。さらに、効率を高めた技術的に先進的な製品のイントロダクションが世界市場の成長を支えています。一方、高コスト、規制当局の厳しい承認手続き、TEO処置の実施には経験豊富なヘルスケア専門家が必要であることなどは、市場開拓にマイナスの影響を与えかねない要因のひとつです。

アジア太平洋のTEO機器市場は、ヘルスケア支出の増加と医療インフラの改善により、2019年から2026年にかけて最も高いCAGRを記録すると予測されています。APACの新興国における医療ツーリズム産業の急速な拡大も、TEO機器の需要を押し上げています。ブラジルは、2018年にラテンアメリカで最も収益を上げた国でした。ヘルスケアサービスの改善、医療ツーリズム産業の成長、同国における規制枠組みの利用可能性が、ブラジルの市場をさらに牽引しています。

経カテーテル塞栓・閉鎖機器市場レポートハイライト

  • コイルが最大シェアを占めるさまざまな形状やサイズのコイルが入手可能であるため、症例に応じて適切な製品を選択することができ、塞栓術の治療法としてコイリングが好まれています。
  • さらに、市販品の価格が手ごろであることも、閉塞治療におけるコイリングの需要に拍車をかけています。
  • 様々な塞栓術や閉塞術においてアクセサリーが広く使用されていることから、アクセサリーは最大のタイプセグメントになると予想されます。
  • 北米と欧州が2022年に最大のシェアを占めました。高度なヘルスケアインフラの存在、保険償還の適用範囲、手技を行う熟練した専門家が、これらの地域の成長を促進する要因の一部です。
  • さらに、高度なヘルスケア治療や製品の迅速な導入と、明確な規制枠組みの存在が、北米と欧州市場を後押ししています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 経カテーテル塞栓・閉鎖機器の市場変数、動向および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • 経カテーテル塞栓・閉鎖機器市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 経カテーテル塞栓・閉鎖機器市場：製品別推定・動向分析

  • 経カテーテル塞栓・閉鎖機器市場：重要なポイント
  • 経カテーテル塞栓・閉鎖機器市場：製品の変動および市場シェア分析、2022年および2030年
  • コイル
  • ノンコイル

第5章 経カテーテル塞栓・閉鎖機器市場：用途別推定・動向分析

  • 経カテーテル塞栓・閉鎖機器市場：重要なポイント
  • 経カテーテル塞栓・閉鎖機器市場：用途の変動と市場シェア分析、2022年および2030年
  • 末梢血管疾患
  • 腫瘍学
  • 神経内科
  • 泌尿器科
  • その他

第6章 経カテーテル塞栓・閉鎖機器市場：地域別推定・動向分析

  • 地域別の見通し
  • 地域別の経カテーテル塞栓・閉鎖機器市場：重要なポイント
  • 北米
    • 北米市場推計・予測、2018～2030年
    • 米国
    • カナダ
  • 欧州
    • 欧州市場推計・予測、2018～2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋地域
    • アジア太平洋市場推計・予測、2018～2030年
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ラテンアメリカ市場推計・予測、2018～2030年
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • MEA市場推計・予測、2018年から2030年
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • Boston Scientific Corporation
    • Terumo Corporation
    • Medtronic
    • DePuy Synthes
    • Stryker
    • Cordis
    • Abbott
    • Pfizer Inc.
    • Sirtex
    • Nordion
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America transcatheter embolization and occlusion devices market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America transcatheter embolization and occlusion devices market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America transcatheter embolization and occlusion devices market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. transcatheter embolization and occlusion devices market, by product, 2018 - 2030 (USD Million)
  • Table 6 U.S. transcatheter embolization and occlusion devices market, by application, 2018 - 2030 (USD Million)
  • Table 7 Canada transcatheter embolization and occlusion devices market, by product, 2018 - 2030 (USD Million)
  • Table 8 Canada transcatheter embolization and occlusion devices market, by application, 2018 - 2030 (USD Million)
  • Table 9 Europe transcatheter embolization and occlusion devices market, by product, 2018 - 2030 (USD Million)
  • Table 10 Europe transcatheter embolization and occlusion devices market, by application, 2018 - 2030 (USD Million)
  • Table 11 Europe transcatheter embolization and occlusion devices market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany transcatheter embolization and occlusion devices market, by product, 2018 - 2030 (USD Million)
  • Table 13 Germany transcatheter embolization and occlusion devices market, by application, 2018 - 2030 (USD Million)
  • Table 14 UK transcatheter embolization and occlusion devices market, by product, 2018 - 2030 (USD Million)
  • Table 15 UK transcatheter embolization and occlusion devices market, by application, 2018 - 2030 (USD Million)
  • Table 16 France transcatheter embolization and occlusion devices market, by product, 2018 - 2030 (USD Million)
  • Table 17 France transcatheter embolization and occlusion devices market, by application, 2018 - 2030 (USD Million)
  • Table 18 Italy transcatheter embolization and occlusion devices market, by product, 2018 - 2030 (USD Million)
  • Table 19 Italy transcatheter embolization and occlusion devices market, by application, 2018 - 2030 (USD Million)
  • Table 20 Spain transcatheter embolization and occlusion devices market, by product, 2018 - 2030 (USD Million)
  • Table 21 Spain transcatheter embolization and occlusion devices market, by application, 2018 - 2030 (USD Million)
  • Table 22 Sweden transcatheter embolization and occlusion devices market, by product, 2018 - 2030 (USD Million)
  • Table 23 Sweden transcatheter embolization and occlusion devices market, by application, 2018 - 2030 (USD Million)
  • Table 24 Norway transcatheter embolization and occlusion devices market, by product, 2018 - 2030 (USD Million)
  • Table 25 Norway transcatheter embolization and occlusion devices market, by application, 2018 - 2030 (USD Million)
  • Table 26 Denmark transcatheter embolization and occlusion devices market, by product, 2018 - 2030 (USD Million)
  • Table 27 Denmark transcatheter embolization and occlusion devices market, by application, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific transcatheter embolization and occlusion devices market, by product, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific transcatheter embolization and occlusion devices market, by application, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific transcatheter embolization and occlusion devices market, by region, 2018 - 2030 (USD Million)
  • Table 31 Japan transcatheter embolization and occlusion devices market, by product, 2018 - 2030 (USD Million)
  • Table 32 Japan transcatheter embolization and occlusion devices market, by application, 2018 - 2030 (USD Million)
  • Table 33 China transcatheter embolization and occlusion devices market, by product, 2018 - 2030 (USD Million)
  • Table 34 China transcatheter embolization and occlusion devices market, by application, 2018 - 2030 (USD Million)
  • Table 35 India transcatheter embolization and occlusion devices market, by product, 2018 - 2030 (USD Million)
  • Table 36 India transcatheter embolization and occlusion devices market, by application, 2018 - 2030 (USD Million)
  • Table 37 Australia transcatheter embolization and occlusion devices market, by product, 2018 - 2030 (USD Million)
  • Table 38 Australia transcatheter embolization and occlusion devices market, by application, 2018 - 2030 (USD Million)
  • Table 39 Thailand transcatheter embolization and occlusion devices market, by product, 2018 - 2030 (USD Million)
  • Table 40 Thailand transcatheter embolization and occlusion devices market, by application, 2018 - 2030 (USD Million)
  • Table 41 South Korea transcatheter embolization and occlusion devices market, by product, 2018 - 2030 (USD Million)
  • Table 42 South Korea transcatheter embolization and occlusion devices market, by application, 2018 - 2030 (USD Million)
  • Table 43 Latin America transcatheter embolization and occlusion devices market, by product, 2018 - 2030 (USD Million)
  • Table 44 Latin America transcatheter embolization and occlusion devices market, by application, 2018 - 2030 (USD Million)
  • Table 45 Latin America transcatheter embolization and occlusion devices market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil transcatheter embolization and occlusion devices market, by product, 2018 - 2030 (USD Million)
  • Table 47 Brazil transcatheter embolization and occlusion devices market, by application, 2018 - 2030 (USD Million)
  • Table 48 Mexico transcatheter embolization and occlusion devices market, by product, 2018 - 2030 (USD Million)
  • Table 49 Mexico transcatheter embolization and occlusion devices market, by application, 2018 - 2030 (USD Million)
  • Table 50 Argentina transcatheter embolization and occlusion devices market, by product, 2018 - 2030 (USD Million)
  • Table 51 Argentina transcatheter embolization and occlusion devices market, by application, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa transcatheter embolization and occlusion devices market, by product, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa transcatheter embolization and occlusion devices market, by application, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa transcatheter embolization and occlusion devices market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa transcatheter embolization and occlusion devices market, by product, 2018 - 2030 (USD Million)
  • Table 56 South Africa transcatheter embolization and occlusion devices market, by application, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia transcatheter embolization and occlusion devices market, by product, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia transcatheter embolization and occlusion devices market, by application, 2018 - 2030 (USD Million)
  • Table 59 UAE transcatheter embolization and occlusion devices market, by product, 2018 - 2030 (USD Million)
  • Table 60 UAE transcatheter embolization and occlusion devices market, by application, 2018 - 2030 (USD Million)
  • Table 61 Kuwait transcatheter embolization and occlusion devices market, by product, 2018 - 2030 (USD Million)
  • Table 62 Kuwait transcatheter embolization and occlusion devices market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Transcatheter embolization and occlusion devices: Market outlook
  • Fig. 9 Transcatheter embolization and occlusion devices: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Transcatheter embolization and occlusion devices market driver impact
  • Fig. 15 Transcatheter embolization and occlusion devices market restraint impact
  • Fig. 16 Transcatheter embolization and occlusion devices market strategic initiatives analysis
  • Fig. 17 Transcatheter embolization and occlusion devices market: Product movement analysis
  • Fig. 18 Transcatheter embolization and occlusion devices market: Product outlook and key takeaways
  • Fig. 19 Coils market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Pushable coils market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Detachable coils market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Non coils market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Flow diverting devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Embolization particles market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Liquid embolics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Other embolization and occlusion devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Accessories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Transcatheter embolization and occlusion devices market: Application movement analysis
  • Fig. 29 Transcatheter embolization and occlusion devices market: Application outlook and key takeaways
  • Fig. 30 Peripheral vascular disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Arterial blockage market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Venous blood clot market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Liver cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Pancreatic cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Breast cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Kidney cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Neurology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Brain aneurysm market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Cerebral arteriovenous malformations market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Urology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Benign prostatic hyperplasia/urinary retention market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Other applications market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Global transcatheter embolization and occlusion devices market: Regional movement analysis
  • Fig. 49 Global transcatheter embolization and occlusion devices market: Regional outlook and key takeaways
  • Fig. 50 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: 978-1-68038-670-7

Transcatheter Embolization And Occlusion Devices Market Growth & Trends:

The global transcatheter embolization and occlusion devices market size is expected to reach USD 8.54 billion by 2030, registering a CAGR of 7.0% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The global market is anticipated to register a strong CAGR of 9.7% from 2019 to 2026. Key drivers of the TEO devices market include increasing adoption of minimally invasive surgeries and rising prevalence of cancer.

In addition, wide usage of embolization technique as a treatment for conditions other than cancer, such as vascular malformations and fibrosis, is fueling the demand for TEO devices globally. Furthermore, introduction of technically advanced products with enhanced efficiency is supporting the global market growth. On the other hand, high cost, stringent regulatory approval procedures, and requirement of experienced healthcare professionals to perform TEO procedures are some of the factors that may have a negative impact on the market development.

Asia Pacific TEO devices market is anticipated to witness highest CAGR from 2019 to 2026 due to increasing healthcare expenditure and improving healthcare infrastructure. Rapid expansion of medical tourism industry in the emerging countries of APAC is also boosting the demand for TEO devices. Brazil was the highest revenue-generating country in Latin America in 2018. Improving healthcare services, growing medical tourism industry, and availability of regulatory framework in the country are further driving the market in Brazil

Transcatheter Embolization And Occlusion Devices Market Report Highlights:

  • Coils accounted for the largest share. Availability of a broad range of coils in various shapes and sizes enables suitable product selection for different cases, making coiling a preferred treatment for embolization
  • Moreover, affordability of the commercially available devices spurs demand for coiling in occlusion
  • Accessories is expected to be the largest type segment due to wide usage of accessories across various modes of embolization and occlusion
  • North America along with Europe accounted for the largest share in 2022. Presence of advanced healthcare infrastructure, reimbursement coverage, and skilled professionals to perform procedures are some of the factors driving the growth of these regionsm
  • Moreover, quick adoption of advanced healthcare treatments and products coupled with the presence of well-defined regulatory framework are boosting North America and Europe markets

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Transcatheter Embolization and Occlusion Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Transcatheter Embolization and Occlusion Devices Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's Five Forces
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Transcatheter Embolization and Occlusion Devices Market: Product Estimates & Trend Analysis

  • 4.1. Transcatheter Embolization and Occlusion Devices Market: Key Takeaways
  • 4.2. Transcatheter Embolization and Occlusion Devices Market: Product Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Coil
    • 4.3.1. Coil market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.2. Pushable coils
      • 4.3.2.1. Pushable coils market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.3. Detachable coils
      • 4.3.3.1. Detachable coils market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Non Coil
    • 4.4.1. Non coil market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Flow diverting devices
      • 4.4.2.1. Flow diverting devices market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Embolization particles
      • 4.4.3.1. Embolization particles market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.4. Liquid embolics
      • 4.4.4.1. Liquid embolics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.5. Other embolization and occlusion devices
      • 4.4.5.1. Other embolization and occlusion devices market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.6. Accessories
      • 4.4.6.1. Accessories market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Transcatheter Embolization and Occlusion Devices Market: Application Estimates & Trend Analysis

  • 5.1. Transcatheter Embolization and Occlusion Devices Market: Key Takeaways
  • 5.2. Transcatheter Embolization and Occlusion Devices Market: Application Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Peripheral Vascular Disease
    • 5.3.1. Peripheral vascular disease market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.2. Arterial blockage
      • 5.3.2.1. Arterial blockage market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.3. Venous blood clot
      • 5.3.3.1. Venous blood clot market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.4. Others
      • 5.3.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Oncology
    • 5.4.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.2. Liver cancer
      • 5.4.2.1. Liver cancer market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.3. Pancreatic cancer
      • 5.4.3.1. Pancreatic cancer market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.4. Breast cancer
      • 5.4.4.1. Breast cancer market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.5. Kidney cancer
      • 5.4.5.1. Kidney cancer market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.6. Others
      • 5.4.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Neurology
    • 5.5.1. Neurology market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.5.2. Brain aneurysm
      • 5.5.2.1. Brain aneurysm market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.5.3. Cerebral arteriovenous malformations
      • 5.5.3.1. Cerebral arteriovenous malformations market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.5.4. Others
      • 5.5.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Urology
    • 5.6.1. Urology market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.6.2. Benign prostatic hyperplasia/urinary retention
      • 5.6.2.1. Benign prostatic hyperplasia/urinary retention market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.6.3. Others
      • 5.6.3.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Transcatheter Embolization and Occlusion Devices Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Transcatheter Embolization and Occlusion Devices Market by Region: Key Takeaway
  • 6.3. North America
    • 6.3.1. North America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. Europe market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. UK
      • 6.4.2.1. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. France
      • 6.4.4.1. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.9. Denmark
      • 6.4.9.1. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. China
      • 6.5.3.1. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. India
      • 6.5.4.1. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Australia
      • 6.5.5.1. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.7. South Korea
      • 6.5.7.1. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Latin America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Mexico
      • 6.6.3.1. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.4. Argentina
      • 6.6.4.1. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. MEA market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. South Africa
      • 6.7.3.1. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. Boston Scientific Corporation
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Terumo Corporation
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Medtronic
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. DePuy Synthes
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Stryker
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Cordis
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Abbott
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Pfizer Inc.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Sirtex
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Nordion
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives